Your session is about to expire
← Back to Search
Covidfree@home for Coronavirus Infection
N/A
Waitlist Available
Led By Robert Wu
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
Study Summary
This trial will use real-time remote patient monitoring to help clinicians detect which patients with Covid19 are at risk of deterioration and need to be brought to the hospital.
Eligible Conditions
- Coronavirus Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants with an unplanned hospital admissions
Number of participants with planned hospital admissions that are found to be necessary
Secondary outcome measures
Number of participants with an emergency department visits not resulting in hospital admission
Number of planned hospital admissions which are found to be unnecessary
Trial Design
1Treatment groups
Experimental Treatment
Group I: Covi19 patients receiving interventionExperimental Treatment1 Intervention
We will collect self-reported symptoms via a questionnaire, temperature and oxygen saturation will be entered by the patient and passive near continuous sensing of heart rate, audio for cough detection, respiratory rate, cough and physical activity from a smart watch. The smart watch then transmits this sensor data to the paired smartphone.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,087 Total Patients Enrolled
Sunnybrook Health Sciences CentreOTHER
656 Previous Clinical Trials
1,550,190 Total Patients Enrolled
University of TorontoOTHER
689 Previous Clinical Trials
1,018,211 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a medical condition that could make it difficult to interpret your symptoms and sensor readings accurately.You do not understand or speak English.You are currently experiencing symptoms of COVID-19 or have been diagnosed with COVID-19.The focus of your medical care is solely on making you comfortable, rather than trying to cure or treat a disease.
Research Study Groups:
This trial has the following groups:- Group 1: Covi19 patients receiving intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the opportunity for participants to join this experiment still available?
"Per the records on clinicaltrials.gov, this particular trial has ended its recruitment process. It was published on November 1st 2020 and last updated two years later, yet 1021 other medical studies are actively accepting patients at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger